FOSTER CITY, CA--(Marketwire - April 16, 2008) - SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it will hold a symposium titled “New Therapies in Liver Cancer and Hepatitis” during the 43rd annual meeting of the European Association for the Study of the Liver (EASL) in Milan, Italy. SciClone and Sigma-Tau will host the meeting on April 24, 2008, from 11:00 a.m. to 12:00 p.m. local time in Hall Yellow 1 in the Milan Convention Center.
